CANF
Can-fite Biopharma·AMEX
--
--(--)
--
--(--)
CANF Filings
Filing Date
Form Description
Form Type
2026-04-01
Form EFFECT - Notice of Effectiveness
2026-04-01 ·
Form EFFECT - Notice of Effectiveness
2026-04-01
Form EFFECT - Notice of Effectiveness
2026-04-01 ·
Form EFFECT - Notice of Effectiveness
2026-03-31
Form F-3 - Registration statement by foreign private issuers
2026-03-31 ·
Form F-3 - Registration statement by foreign private issuers
2026-03-31
Form POS AM - Post-Effective amendments for registration statement
2026-03-31 ·
Form POS AM - Post-Effective amendments for registration statement
2026-03-31
Form POS AM - Post-Effective amendments for registration statement
2026-03-31 ·
Form POS AM - Post-Effective amendments for registration statement
2026-03-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-30 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-26
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Financials
2026-03-26 · Financials
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026-03-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2026-03-26 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-18
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-18 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-03-18
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-18 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
